Cargando…
The content validity of the ANMS GCSI-DD in patients with idiopathic or diabetic gastroparesis
BACKGROUND: The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD) was developed to meet Food and Drug Administration (FDA) recommendations for patient-reported outcome (PRO) endpoints in gastroparesis studies, including therapeutic tr...
Autores principales: | Revicki, Dennis A., Lavoie, Sara, Speck, Rebecca M., Puelles, Jorge, Kuo, Braden, Camilleri, Michael, Almansa, Cristina, Parkman, Henry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292831/ https://www.ncbi.nlm.nih.gov/pubmed/30547386 http://dx.doi.org/10.1186/s41687-018-0081-2 |
Ejemplares similares
-
Health‐care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis
por: Chen, Yaozhu J., et al.
Publicado: (2022) -
Ultrastructural differences between diabetic and idiopathic gastroparesis
por: Faussone-Pellegrini, Maria Simonetta, et al.
Publicado: (2012) -
Transcriptomic signatures reveal immune dysregulation in human diabetic and idiopathic gastroparesis
por: Grover, Madhusudan, et al.
Publicado: (2018) -
Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis
por: McCallum, R W, et al.
Publicado: (2013) -
Mirtazapine for symptom control in refractory gastroparesis
por: Malamood, Mark, et al.
Publicado: (2017)